Amir Khan, the former world champion boxer, has been barred from participating in any sport for two years after testing positive for ostarine, a banned performance-enhancing drug, on the night he lost to his bitter rival Kell Brook last year.
On February 19, 2022, shortly after Brook brutally stopped him in the sixth round of their one-sided fight in Manchester, Khan provided a urine sample to a UK Anti-Doping official (Ukad). A positive ostarine test result was obtained.
On Tuesday, Ukad announced Khan’s ban, saying ostarine “is listed on the World Anti-Doping Agency’s (Wada) 2022 Prohibited List as an anabolic agent and is prohibited in sport at all times.”
Also Read: Manchester City accused by the Premier League of breaking financial rules. Copy
Khan, who had retired following his loss to Brook, was notified of the positive outcome on April 6, 2022, and was given a provisional and confidential suspension. Ukad then formally charged Khan with two anti-doping rule violations on July 20. The boxer accepted the charge, but insisted that his consumption of ostarine was unintentional.
In late January, an independent tribunal heard Khan’s case, and on February 21, its written decision stated that the panel “concluded that Mr Khan had established that they were not ‘intentional’ within the meaning of ADR Article 10.2.3 and imposed a two-year ban on him.” The panel also ruled that Mr Khan’s victory over Mr Brook was invalid. Mr Khan’s two-year ban is set to begin on April 6, 2022, and will end on April 5, 2024.”
